Heterodox
I had thought these types of treatment had gone by the wayside in treatment during the last year of life. According to an Medscape article they have not. “‘Physicians should carefully consider whether the prescribed drugs are likely to achieve their benefit within the patient’s remaining lifetime,’ the authors concluded. The study included 151,201 patients ages 65 years and older who died in Sweden at a mean age of 81.3 years from 2007 to 2013. ‘The use...
Read More »